Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonia Puchner

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of Cellular and Molecular Medicine|August 23, 2018
CCR6 controls autoimmune but not innate immunity-driven experimental arthritisMichael Bonelli, Antonia Puchner, Lisa Göschl, et al.
Wiener Klinische Wochenschrift|January 16, 2019
Immunosuppressives and biologics during pregnancy and lactation : A consensus report issued by the Austrian Societies of Gastroenterology and Hepatology and Rheumatology and RehabilitationAntonia Puchner, Hans Peter Gröchenig, Judith Sautner, et al.
Frontiers in Immunology|July 6, 2019
MicroRNA-155 Controls T Helper Cell Activation During Viral InfectionEliana Goncalves-Alves, Victoria Saferding, Christopher Schliehe, et al.
Annals of the Rheumatic Diseases|December 10, 2023
Bona fide dendritic cells are pivotal precursors for osteoclastsAntonia Puchner, Elisabeth Simader, Victoria Saferding, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 5, 2017
Therapeutic Modulation of Plasmacytoid Dendritic Cells in Experimental ArthritisRamzi Nehmar, Ghada Alsaleh, Benjamin Voisin, et al.
Journal of Autoimmunity|May 27, 2017
MicroRNA-146a governs fibroblast activation and joint pathology in arthritisVictoria Saferding, Antonia Puchner, Eliana Goncalves-Alves, et al.
Annals of the Rheumatic Diseases|July 1, 2018
Non-classical monocytes as mediators of tissue destruction in arthritisAntonia Puchner, Victoria Saferding, Michael Bonelli, et al.
Annals of the Rheumatic Diseases|September 15, 2022
Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controlsFelix Kartnig, Daniel Mrak, Elisabeth Simader, et al.
Nature Communications|September 12, 2022
Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trialDaniel Mrak, Daniela Sieghart, Elisabeth Simader, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Cellular and Molecular Medicine|August 23, 2018
CCR6 controls autoimmune but not innate immunity-driven experimental arthritisMichael Bonelli, Antonia Puchner, Lisa Göschl, et al.
Wiener Klinische Wochenschrift|January 16, 2019
Immunosuppressives and biologics during pregnancy and lactation : A consensus report issued by the Austrian Societies of Gastroenterology and Hepatology and Rheumatology and RehabilitationAntonia Puchner, Hans Peter Gröchenig, Judith Sautner, et al.
Frontiers in Immunology|July 6, 2019
MicroRNA-155 Controls T Helper Cell Activation During Viral InfectionEliana Goncalves-Alves, Victoria Saferding, Christopher Schliehe, et al.
Annals of the Rheumatic Diseases|December 10, 2023
Bona fide dendritic cells are pivotal precursors for osteoclastsAntonia Puchner, Elisabeth Simader, Victoria Saferding, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 5, 2017
Therapeutic Modulation of Plasmacytoid Dendritic Cells in Experimental ArthritisRamzi Nehmar, Ghada Alsaleh, Benjamin Voisin, et al.
Journal of Autoimmunity|May 27, 2017
MicroRNA-146a governs fibroblast activation and joint pathology in arthritisVictoria Saferding, Antonia Puchner, Eliana Goncalves-Alves, et al.
Annals of the Rheumatic Diseases|July 1, 2018
Non-classical monocytes as mediators of tissue destruction in arthritisAntonia Puchner, Victoria Saferding, Michael Bonelli, et al.
Annals of the Rheumatic Diseases|September 15, 2022
Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controlsFelix Kartnig, Daniel Mrak, Elisabeth Simader, et al.
Nature Communications|September 12, 2022
Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trialDaniel Mrak, Daniela Sieghart, Elisabeth Simader, et al.
Pageof 2